PlainRecalls
FDA Drug Moderate Class II Terminated

Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7474-89

Reported: March 9, 2016 Initiated: December 21, 2015 #D-0732-2016

Product Description

Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7474-89

Reason for Recall

Failed Dissolution Specifications: low test results at the 18 month time-point

Details

Recalling Firm
Teva North America
Units Affected
1,895 bottles
Distribution
Nationwide
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7474-89. Recalled by Teva North America. Units affected: 1,895 bottles.
Why was this product recalled?
Failed Dissolution Specifications: low test results at the 18 month time-point
Which agency issued this recall?
This recall was issued by the FDA Drug on March 9, 2016. Severity: Moderate. Recall number: D-0732-2016.